Macquarie Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,791,235
| Closed | -$16M | – | 1705 |
|
|
2025
Q1 | $16M | Buy |
4,791,235
+40,301
| +0.8% | +$134K | 0.02% | 718 |
|
|
2024
Q4 | $35.2M | Buy |
4,750,934
+1,560,898
| +49% | +$11.6M | 0.04% | 505 |
|
|
2024
Q3 | $30M | Buy |
+3,190,036
| New | +$30M | 0.03% | 584 |
|
|
2024
Q2 | – | Sell |
-122,053
| Closed | -$1.81M | – | 2008 |
|
|
2024
Q1 | $1.81M | Buy |
+122,053
| New | +$1.81M | ﹤0.01% | 1248 |
|
|
2023
Q2 | – | Sell |
-55,835
| Closed | -$341K | – | 1682 |
|
|
2023
Q1 | $341K | Sell |
55,835
-674
| -1% | -$4.12K | ﹤0.01% | 1501 |
|
|
2022
Q4 | $361K | Sell |
56,509
-7,347
| -12% | -$46.9K | ﹤0.01% | 1551 |
|
|
2022
Q3 | $634K | Sell |
63,856
-2,537
| -4% | -$25.2K | ﹤0.01% | 1490 |
|
|
2022
Q2 | $733K | Buy |
66,393
+1,721
| +3% | +$19K | ﹤0.01% | 1542 |
|
|
2022
Q1 | $1.08K | Buy |
64,672
+7,019
| +12% | +$117 | ﹤0.01% | 1533 |
|
|
2021
Q4 | $1.1M | Buy |
57,653
+9,472
| +20% | +$181K | ﹤0.01% | 1537 |
|
|
2021
Q3 | $1.19M | Sell |
48,181
-1,700
| -3% | -$41.9K | ﹤0.01% | 1542 |
|
|
2021
Q2 | $1.3M | Buy |
49,881
+6,343
| +15% | +$165K | ﹤0.01% | 1543 |
|
|
2021
Q1 | $1.38M | Buy |
43,538
+4,609
| +12% | +$146K | ﹤0.01% | 1312 |
|
|
2020
Q4 | $1.81M | Sell |
38,929
-12,046
| -24% | -$559K | ﹤0.01% | 1135 |
|
|
2020
Q3 | $1.68M | Sell |
50,975
-1,189
| -2% | -$39.2K | ﹤0.01% | 1090 |
|
|
2020
Q2 | $1.43M | Buy |
52,164
+6,809
| +15% | +$187K | ﹤0.01% | 1112 |
|
|
2020
Q1 | $1.36M | Sell |
45,355
-16,137
| -26% | -$483K | ﹤0.01% | 1014 |
|
|
2019
Q4 | $1.7M | Sell |
61,492
-2,132
| -3% | -$59K | ﹤0.01% | 1084 |
|
|
2019
Q3 | $1.16M | Buy |
63,624
+34
| +0.1% | +$619 | ﹤0.01% | 1174 |
|
|
2019
Q2 | $1.56M | Sell |
63,590
-13,620
| -18% | -$334K | ﹤0.01% | 1084 |
|
|
2019
Q1 | $734K | Buy |
+77,210
| New | +$734K | ﹤0.01% | 1253 |
|